Pancreatic Cancer Research

ResearcherCancer Research UK Scotland InstituteActive in the last 2 years

Dale M. Watt

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0443-176X; OpenAlex author ID A5000424441. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition. Co-author DOI 10.1158/0008-5472.can-23-2709↗
  2. Heterogeneity in Pancreatic Cancer Fibroblasts-TGFβ as a Master Regulator? Co-author DOI 10.3390/cancers13194984↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jennifer P. Morton · 2 shared papers, 2021–2025 · strength 0.48
  2. Joanna L. Birch · 1 shared paper, 2025 · strength 0.20
  3. Simon T. Barry · 1 shared paper, 2025 · strength 0.20
  4. Kathy McLay · 1 shared paper, 2025 · strength 0.20
  5. Sigrid K. Fey · 1 shared paper, 2025 · strength 0.20
  6. David Kuang-Fu Chang · 1 shared paper, 2025 · strength 0.20
  7. Owen James Sansom · 1 shared paper, 2025 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.